About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Lupin Gets USFDA Approval For Quinapril Tablets

by Medindia Content Team on June 23, 2006 at 5:32 PM
Font : A-A+

Lupin Gets USFDA Approval For Quinapril Tablets

Pharmaceutical company Lupin Ltd today said it has recieved the final approval from USFDA to market its Abbreviated New Drug Application (ANDA) of hypertension medicine Quinapril in US.

The company informed the Bombay Stock Exchange that the approval is for the multiple dosages of strengths 5 mg, 10 mg, 20 mg and 40 mg.

Advertisement

Quinapril is a AB-rated generic equivalent of Pfizer's hypertension drug Accupril and its market is estimated to be about 300 million dollars in the US till December 2005.

This is the company's 13th ANDA aprroval by USFDA till date and third in the current fiscal.

(Source:PTI News)
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Get Involved and Stand Up for Human Rights on Human Rights Day 2022
Coronary Artery Bypass Grafting
Macronutrients Calculator for Weight Loss
View all
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

Most Popular on Medindia

Diaphragmatic Hernia The Essence of Yoga Daily Calorie Requirements Accident and Trauma Care Drug Side Effects Calculator Hearing Loss Calculator Pregnancy Confirmation Calculator Drug - Food Interactions Loram (2 mg) (Lorazepam) Sanatogen
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Lupin Gets USFDA Approval For Quinapril Tablets Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests